Authors:
ROUSSEAUPLASSE A
WDZIECZAKBAKALA J
LENFANT M
EZAN E
GENET R
ROBINSON S
BRISCOE T
MELVILLE J
RICHES A
Citation: A. Rousseauplasse et al., LISINOPRIL, AN ANGIOTENSIN-I-CONVERTING-ENZYME INHIBITOR, PREVENTS ENTRY OF MURINE HEMATOPOIETIC STEM-CELLS INTO THE CELL-CYCLE AFTER IRRADIATION IN-VIVO, Experimental hematology, 26(11), 1998, pp. 1074-1079
Citation: Jl. Reny et al., INFLUENCE OF RENAL-FAILURE AND ANGIOTENSIN-CONVERTING INHIBITION ON THE HEMOREGULATORY PEPTIDE N-ACETYL-SERYL-ASPARTYL-LYSYL-PROLINE (ACSDKP) IN PLASMA, Journal of hypertension, 16, 1998, pp. 1739-1739
Authors:
NICOLET L
EZAN E
AZIZI M
GONZALEZ MF
MENARD J
Citation: L. Nicolet et al., INFLUENCE OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON PLASMA, URINARY AND TISSUE-LEVELS OF THE HEMOREGULATORY PEPTIDE N-ACETYL-SERYL-ASPARTYL-LYSYL-PROLINE (ACSDKP) IN RATS, Journal of hypertension, 16, 1998, pp. 1747-1747
Citation: M. Azizi et E. Ezan, IS PLASMA AC-SDKP LEVEL A RELIABLE MARKER OF CHRONIC ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN HYPERTENSIVE PATIENTS - RESPONSE, Hypertension, 31(5), 1998, pp. 1201-1202
Authors:
BOULANGER CM
EZAN E
MASSE F
MATHIEU E
LEVY BI
AZIZI M
Citation: Cm. Boulanger et al., THE HEMOREGULATORY PEPTIDE N-ACETYL-SER-ASP-LYS-PRO (AC-SDKP) IMPAIRSCONTRACTIONS TO ANGIOTENSIN-I IN THE RAT AORTA, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 148-148
Citation: S. Orlowski et al., BROMOCRIPTINE MODULATES P-GLYCOPROTEIN FUNCTION, Biochemical and biophysical research communications, 244(2), 1998, pp. 481-488
Authors:
DEVERRE JR
BOUTET V
BOQUET D
EZAN E
GRASSI J
GROGNET JM
Citation: Jr. Deverre et al., A COMPETITIVE ENZYME HYBRIDIZATION ASSAY FOR PLASMA DETERMINATION OF PHOSPHODIESTER AND PHOSPHOROTHIOATE ANTISENSE OLIGONUCLEOTIDES, Nucleic acids research, 25(18), 1997, pp. 3584-3589
Authors:
WDZIECZAKBAKALA J
ROUSSEAUPLASSE A
LENFANT M
EZAN E
ROBINSON S
RICHES A
Citation: J. Wdzieczakbakala et al., LISINOPRIL, AN ANGIOTENSIN I-CONVERTING ENZYME-INHIBITOR, PREVENTS IN-VIVO THE ENTRY INTO CELL-CYCLE OF MURINE HEMATOPOIETIC STEM-CELLS FOLLOWING IRRADIATION, Experimental hematology, 25(8), 1997, pp. 161-161
Authors:
EZAN E
LAPLANTE E
BLUETPAJOT MT
MOUNIER F
MAMAS S
GROUSELLE D
GROGNET JM
KORDON C
Citation: E. Ezan et al., AN ENZYME-IMMUNOASSAY FOR RAT GROWTH-HORMONE - VALIDATION AND APPLICATION TO THE DETERMINATION OF PLASMA-LEVELS AND IN-VITRO RELEASE, Journal of immunoassay, 18(4), 1997, pp. 335-356
Authors:
AZIZI M
EZAN E
NICOLET L
GROGNET JM
MENARD J
Citation: M. Azizi et al., HIGH PLASMA-LEVEL OF N-ACETYL-SERYL-ASPARTYL-LYSYL-PROLINE - A NEW MARKER OF CHRONIC ANGIOTENSIN-CONVERTING ENZYME-INHIBITION, Hypertension, 30(5), 1997, pp. 1015-1019
Citation: E. Ezan et al., EFFECT OF VARIABILITY OF PLASMA INTERFERENCES ON THE ACCURACY OF DRUGIMMUNOASSAYS, Therapeutic drug monitoring, 19(2), 1997, pp. 212-218
Authors:
VALENTE D
DELAFORGE M
URIEN S
GUIVARCH D
VIENET R
GROGNET JM
EZAN E
Citation: D. Valente et al., METABOLITE INVOLVEMENT IN BROMOCRIPTINE-INDUCED PROLACTIN INHIBITION IN RATS, The Journal of pharmacology and experimental therapeutics, 282(3), 1997, pp. 1418-1424
Authors:
EZAN E
ARDOUIN T
LANDES BD
FLOUVAT B
HANSLIK T
LEGEAI JM
GROGNET JM
Citation: E. Ezan et al., BIOEQUIVALENCE STUDY OF ALPHA-DIHYDROERGOCRYPTINE - UTILITY OF METABOLITE EVALUATION, International journal of clinical pharmacology and therapeutics, 34(1), 1996, pp. 32-37
Authors:
AZIZI M
ROUSSEAU A
EZAN E
GUYENE TT
MICHELET S
GROGNET JM
LENFANT M
CORVOL P
MENARD J
Citation: M. Azizi et al., ACUTE ANGIOTENSIN-CONVERTING ENZYME-INHIBITION INCREASES THE PLASMA-LEVEL OF THE NATURAL STEM-CELL REGULATOR N-ACETYL-SERYL-ASPARTYL-LYSYL-PROLINE, The Journal of clinical investigation, 97(3), 1996, pp. 839-844
Authors:
VIENET R
GROGNET JM
EZAN E
LECAQUE D
HAMON G
CORMAN B
Citation: R. Vienet et al., EFFECT OF CHRONIC CONVERTING-ENZYME INHIBITION ON KIDNEY-FUNCTION OF SENESCENT HYPERTENSIVE RATS, Journal of cardiovascular pharmacology, 23, 1994, pp. 190000019-190000025
Authors:
EZAN E
CARDE P
LEKERNEAU J
ARDOUIN T
THOMAS F
ISNARD F
DEPAILLETTE ED
GROGNET JM
Citation: E. Ezan et al., PHARMACOKINETICS IN HEALTHY-VOLUNTEERS AND PATIENTS OF NAC-SDKP (SERASPENIDE), A NEGATIVE REGULATOR OF HEMATOPOIESIS, Drug metabolism and disposition, 22(6), 1994, pp. 843-848
Authors:
EZAN E
DUCANCEL F
GILLET D
DREVET P
MENEZ A
GROGNET JM
BOULAIN JC
Citation: E. Ezan et al., RECOMBINANT TECHNOLOGY IN THE PREPARATION OF IMMUNOGEN AND ENZYMATIC TRACER - APPLICATION TO THE DEVELOPMENT OF AN ENZYME-IMMUNOASSAY FOR RAT PROLACTIN, Journal of immunological methods, 169(2), 1994, pp. 205-211
Authors:
HEUDES D
MICHEL O
CHEVALIER J
SCALBERT E
EZAN E
BARIETY J
ZIMMERMAN A
CORMAN B
Citation: D. Heudes et al., EFFECT OF CHRONIC ANG I-CONVERTING ENZYME-INHIBITION ON AGING PROCESSES .1. KIDNEY STRUCTURE AND FUNCTION, The American journal of physiology, 266(3), 1994, pp. 180001038-180001051
Authors:
EZAN E
BENECH H
BUCOURT R
ARDOUIN T
TCHERNATINSKY C
THOMAS JL
PARIS J
GROGNET JM
Citation: E. Ezan et al., ENZYME-IMMUNOASSAY FOR NOMEGESTROL ACETATE IN HUMAN PLASMA, Journal of steroid biochemistry and molecular biology, 46(4), 1993, pp. 507-514
Authors:
EZAN E
MORGE X
LELIEVRE E
CREMINON C
PIRAUBE C
GROGNET JM
Citation: E. Ezan et al., ENZYME IMMUNOASSAYS FOR A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, ZABICIPRIL, AND ITS ACTIVE METABOLITE IN HUMAN PLASMA - APPLICATION TO PHARMACOKINETIC STUDIES, Therapeutic drug monitoring, 15(5), 1993, pp. 448-454
Authors:
GILLET D
EZAN E
DUCANCEL F
GAILLARD C
ARDOUIN T
ISTIN M
MENEZ A
BOULAIN JC
GROGNET JM
Citation: D. Gillet et al., ENZYME-IMMUNOASSAY USING A RAT PROLACTIN ALKALINE-PHOSPHATASE RECOMBINANT TRACER, Analytical chemistry, 65(13), 1993, pp. 1779-1784